Close X
Sunday, November 24, 2024
ADVT 
National

EU regulator advises AstraZeneca's COVID drug be cleared

Darpan News Desk The Canadian Press, 24 Mar, 2022 12:41 PM
  • EU regulator advises AstraZeneca's COVID drug be cleared

LONDON (AP) — The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.

The European Medicines Agency said in a statement that it was advising the use of the new drug, sold as Evusheld, in people age 12 and over before they were exposed to COVID-19, to prevent future infections.

It is now up to the EU's executive arm, the European Commission, to officially authorize the drug.

The U.S. Food and Drug Administration cleared the medication in December for people with serious health problems or allergies who can’t get adequate protection from vaccination. Britain authorized the use of Evusheld last week.

“When the antibodies in Evusheld attach to the spike protein, the virus cannot enter the cells to multiply and is unable to cause COVID-19 infection,” the EMA said. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated to last at least six months.

EMA said the drug's side effects were mostly mild, with some people reporting reactions at the injection point. The agency noted that research was done before the emergence of the hugely infectious omicron variant and said that it was evaluating data to determine if a different dose might be needed.

Although antibody drugs have been a standard treatment for treating COVID-19 infections for more than a year, AstraZeneca's is the first intended for long-term prevention against COVID-19 infection rather than as a short-term treatment.

People who could benefit from the antibody drug include cancer patients, organ transplant recipients and individuals taking immune-suppressing drugs for conditions like rheumatoid arthritis.

___

 

MORE National ARTICLES

Vaccinated travellers won't need COVID-19 test to enter Canada as of April 1

Vaccinated travellers won't need COVID-19 test to enter Canada as of April 1
 The change is being made at the tail end of the Omicron wave in Canada, as new reported cases of COVID-19 have declined since mid-January. Duclos said the change is possible because of Canada's high vaccination rates and fewer cases of the virus being detected at the border.

Vaccinated travellers won't need COVID-19 test to enter Canada as of April 1

WHO may reject sole Canadian-made COVID-19 vaccine

WHO may reject sole Canadian-made COVID-19 vaccine
The World Health Organization says it expects to reject the COVID-19 vaccine candidate from Canada's Medicago because of the company's ties to big tobacco. The two-dose Medicago Covifenz vaccine was authorized in Canada last month for adults between 18 and 64 years old.

WHO may reject sole Canadian-made COVID-19 vaccine

Arson to two vehicles in Fraser Heights area of Surrey

Arson to two vehicles in Fraser Heights area of Surrey
Based on an inspection it was determined that the vehicles were intentionally lit on fire. Although this incident appears to be targeted, a motive has not yet been determined and the vehicle owners are not known to police.

Arson to two vehicles in Fraser Heights area of Surrey

235 COVID19 cases for Wednesday

235 COVID19 cases for Wednesday
There are 329 individuals hospitalized with COVID-19 and 51 are in intensive care. In the past 24 hours, eight new deaths have been reported, for an overall total of 2,953.

235 COVID19 cases for Wednesday

B.C. to review its COVID-19 pandemic response

B.C. to review its COVID-19 pandemic response
Public Safety Minister Mike Farnworth has appointed a three-person team including two former deputy ministers and a public policy consultant to do the review.

B.C. to review its COVID-19 pandemic response

Amnesty on 'assault-style' firearms extended

Amnesty on 'assault-style' firearms extended
Prime Minister Justin Trudeau announced in May 2020 he was banning more than 1,500 models of firearms, including the AR-15. He also announced owners of these guns would have a two-year amnesty period to come into compliance with the prohibition.

Amnesty on 'assault-style' firearms extended